José Cervera Selected Research

José Cervera Research Topics

Disease

13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 08/2002
9	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2021 - 08/2002
5	Neoplasms (Cancer) 10/2020 - 08/2002
5	Acute Promyelocytic Leukemia 01/2011 - 11/2004
3	Chromosome Aberrations (Chromosome Abnormalities) 09/2012 - 09/2007
3	Leukemia 10/2008 - 12/2006
2	Residual Neoplasm 10/2021 - 01/2002
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 11/2004
1	Polycythemia Vera 01/2021
1	Bronchiolitis Obliterans Syndrome 09/2019
1	Mycoses (Diseases, Fungus) 09/2019
1	Hematologic Diseases (Blood Diseases) 01/2019
1	Eosinophilia 01/2019
1	Hemolytic Anemia 10/2018
1	Thrombotic Microangiopathies 10/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2016
1	Lung Neoplasms (Lung Cancer) 06/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2016
1	Carcinogenesis 12/2013
1	Disease Progression 07/2013
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 03/2012
1	Osteonecrosis (Kienbock's Disease) 10/2011
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 10/2011
1	Multiple Myeloma 10/2011
1	Multiple Sclerosis 10/2008
1	Breast Neoplasms (Breast Cancer) 10/2008
1	Pathologic Complete Response 09/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2007

Drug/Important Bio-Agent (IBA)

3	AnthracyclinesIBA 01/2021 - 03/2010
3	Pharmaceutical PreparationsIBA 07/2013 - 02/2007
3	EnzymesIBA 03/2007 - 12/2006
2	Biological ProductsIBA 10/2020 - 08/2004
2	Azacitidine (5 Azacytidine)FDA Link 01/2018 - 12/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2017 - 08/2002
2	Biomarkers (Surrogate Marker)IBA 06/2016 - 09/2012
2	MicroRNAs (MicroRNA)IBA 06/2016 - 12/2013
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2011 - 03/2007
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2010 - 11/2004
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 09/2007 - 08/2002
1	RNA Splicing FactorsIBA 06/2021
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2021
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019
1	BilirubinIBA 10/2018
1	Transcription Factors (Transcription Factor)IBA 12/2013
1	Lenalidomide (CC 5013)FDA Link 07/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2012
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 03/2012
1	Diphosphonates (Bisphosphonates)IBA 10/2011
1	Peptides (Polypeptides)IBA 10/2011
1	Histones (Histone)IBA 10/2011
1	Cytochrome P-450 CYP2C8IBA 10/2011
1	Lysine (L-Lysine)FDA Link 10/2011
1	nuclear pore complex protein 98IBA 01/2011
1	Core Binding Factors (Core-Binding Factor)IBA 09/2009
1	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2008
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2008
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 03/2007
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 03/2007
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 03/2007
1	Cytochrome P-450 CYP3AIBA 03/2007
1	quinone (benzoquinone)IBA 03/2007
1	Thymidylate SynthaseIBA 03/2007
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2007
1	locked nucleic acidIBA 11/2004
1	Monoclonal AntibodiesIBA 11/2004
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2002
1	fludarabineIBA 08/2002

Therapy/Procedure

7	Therapeutics 10/2021 - 11/2004
3	Induction Chemotherapy 01/2021 - 01/2017
3	Drug Therapy (Chemotherapy) 09/2019 - 01/2002
1	Hematopoietic Stem Cell Transplantation 09/2019
1	Emergency Treatment 10/2018
1	Precision Medicine 11/2016
1	Aftercare (After-Treatment) 10/2008